# An Emerging Paradigm for Safer and Faster Recovery: A Narrative Review on Opioid Sparing Anesthesia in Surgery

## TL;DR

Opioid-free anesthesia reduces side effects and speeds recovery after surgery, but more research is needed to optimize its use and safety.

## Contribution

This paper reviews the current evidence and proposes a pragmatic opioid-sparing approach for safer and faster surgical recovery.

## Key findings

- OFA is linked to lower postoperative nausea and vomiting and faster gastrointestinal recovery.
- OFA reduces rescue opioid use without worsening pain scores in many trials.
- Safety concerns include hypotension and prolonged sedation with α2-agonists like dexmedetomidine.

## Abstract

Opioid-free anesthesia (OFA) replaces opioid use with many non-opioid drugs, such as dexmedetomidine, lidocaine, esketamine, regional techniques, and enhanced recovery after surgery (ERAS)-aligned strategies to control pain while minimizing opioid-related adverse effects. Across surgical procedures, we conducted a narrative review of the literature, which showed that OFA is consistently associated with lower postoperative nausea and vomiting, faster recovery of gastrointestinal function, and reduced rescue opioid use, with similar post-anesthesia care unit (PACU) stay and pain scores in many trials. Pediatric and ambulatory settings also show fewer emetogenic symptoms and quicker readiness for discharge. However, evidence quality is mixed: several randomized trials and meta-analyses report meaningful reductions in PONV and opioid consumption but only modest or clinically marginal analgesic gains. Safety signals-particularly with α2-agonists like dexmedetomidine-include intraoperative hypotension/bradycardia and potential prolonged sedation, underscoring the need for careful dosing and patient selection. Contemporary guidance therefore favors opioid-sparing (minimizing rather than eliminating opioids) as a pragmatic interim goal while high-quality trials further define OFA’s net benefit, optimal drug combinations, and perioperative extensions (e.g., postoperative low-dose infusions). Future work should refine protocols that de-emphasize routine lidocaine, titrate dexmedetomidine judiciously, and integrate targeted regional blocks to balance recovery benefits with hemodynamic safety, particularly in high-risk populations such as those with obesity or sleep apnea.